SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Infectious Diseases (travel medicine) Consultation — Pierre Le Moyne d'Iberville

PatientPierre Le Moyne d'Iberville
Date of birth1982-07-16
IdentifiersMRN HR-ET014-SYN; SSN (made up) 000-14-7260
Document date2026-03-03
AuthorJean-Baptiste Okonkwo-Hale, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Referral

Three episodes of fever with shaking chills and sweats in two years, each beginning months after naval service in malaria-endemic areas, the first called malaria abroad and treated with chloroquine alone, in a 43-year-old naval commander who is afebrile today. Please establish whether these are malaria relapses, advise on antirelapse treatment, and plan his pre-travel care for a deployment to French Guiana and the French Antilles expected early next year. [S]

Urgency: Within two weeks; same day if he develops a fever. [S]

Questions for the consultant:

History of Present Illness

Mr. Le Moyne d'Iberville, a 43-year-old naval commander, is seen at the request of Dr. Delacroix-Boateng for recurrent fevers. Over two years he has had three attacks, each about a week of fever with shaking chills every other day, drenching sweats and headache, each beginning months after he left a posting on the Caribbean coast of Central America or the Gulf of Mexico. The first attack was diagnosed as malaria on a smear abroad, species not recorded, and all three were treated with chloroquine alone; he has never taken primaquine or tafenoquine. The last attack ended eight weeks ago and he has had no fever since. He takes no medicines and has no allergies. He is preparing a squadron for a deployment to the French Antilles and French Guiana early next year, with months ashore and possible inland river work. [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

3 later historical claims are omitted because they describe events after the index age. See the teaching note.

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Chloroquine phosphate 500 mg tablet: 1,000 mg (two tablets) at once, then 500 mg at 6, 24 and 48 hours; take with food1,000 mg, then 500 mg at 6, 24 and 48 hours (2,500 mg salt in total)Oral route2026-03-03 to 2026-03-05completedS
Primaquine phosphate 26.3 mg tablet (15 mg base): two tablets (30 mg base) by mouth daily with food for 14 days30 mg base once daily for 14 daysOral route2026-03-03 to 2026-03-16completedS

Problems

ProblemClinical statusVerificationCodeProvenance
Recurrent episodes of fever with shaking chills and drenching sweats, three in the past two years, each beginning months after naval service in malaria-endemic areas; the first diagnosed as malaria abroad on a blood smear with the species not recorded and treated with chloroquine alone, the later two treated with chloroquine without testing; the last ended six weeks before intake; afebrile and well at intake; cause not established at intake; infectious diseases consultation requestedresolvedconfirmed R50.9S — Synthetic presenting problem anchored to his documented recurrent attacks of illness called malaria; superseded by the diagnosis at the infectious diseases consultation.
Relapsing Plasmodium vivax malaria: P. vivax DNA detected by PCR in blood drawn between attacks, with negative smears and rapid antigen test; after three relapses treated without antirelapse therapy; normal quantitative G6PDactiveconfirmed B51.9S — Synthetic modern diagnosis made at the infectious diseases consultation, linked to his documented recurrent attacks of illness called malaria; the species and the PCR result are synthetic.
Pre-travel care for a naval deployment, expected to sail early next year, to French Guiana and the French Antilles: yellow fever vaccination required for entry to French Guiana, malaria prevention, dengue, chikungunya and typhus prevention by vector avoidance, food and water safety, and travel vaccinesactiveconfirmed Z71.84S — Synthetic modern counterpart of his documented preparation of a tropical campaign in 1705.

Physical Exam

Vital signs recorded on 2026-03-03; see the referring visit's Vital Signs section. [S]

SystemFinding
GeneralWell; temperature 36.6 C, blood pressure 122/76, pulse 68
EyesMild conjunctival pallor; no jaundice
AbdomenSpleen tip not palpable; liver not enlarged
SkinNo rash

Assessment

Data reviewed: Dr. Delacroix-Boateng's intake note and tests: thick and thin smears and rapid antigen test negative; Plasmodium species PCR from the intake sample, reported this week, detected P. vivax DNA; hemoglobin 13.0 g/dL, platelets 141 x10^3/uL, white cells 5.6 x10^3/uL, bilirubin 1.1 mg/dL, ALT 34 U/L, AST 29 U/L, creatinine 0.98 mg/dL, glucose 92 mg/dL; quantitative G6PD activity 11.8 U/g Hb, within the laboratory's normal range. [S]

Plan of Treatment